M. Caporale

465 total citations
16 papers, 149 citations indexed

About

M. Caporale is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, M. Caporale has authored 16 papers receiving a total of 149 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in M. Caporale's work include SARS-CoV-2 and COVID-19 Research (4 papers), SARS-CoV-2 detection and testing (4 papers) and Gastric Cancer Management and Outcomes (4 papers). M. Caporale is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), SARS-CoV-2 detection and testing (4 papers) and Gastric Cancer Management and Outcomes (4 papers). M. Caporale collaborates with scholars based in Italy, Australia and United States. M. Caporale's co-authors include Alessio Lorusso, Giacomo Migliorati, Filippo de Braud, Filippo Pietrantonio, Massimo Ancora, Laura Amato, Ilaria Puglia, Ottavio Portanti, Rosa Berenato and Paolo Calistri and has published in prestigious journals such as Annals of Oncology, Virology and International Journal of Infectious Diseases.

In The Last Decade

M. Caporale

11 papers receiving 145 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Caporale Italy	6	76	54	35	27	15	16	149
Léo Plaçais France	7	63 0.8×	9 0.2×	42 1.2×	5 0.2×	11 0.7×	20	160
Sona Dharmendra India	10	107 1.4×	254 4.7×	91 2.6×	34 1.3×	3 0.2×	18	386
Ashalatha Ganesh India	7	30 0.4×	49 0.9×	220 6.3×	4 0.1×	7 0.5×	11	305
Alexandre Pérez‐González Spain	9	63 0.8×	26 0.5×	2 0.1×	10 0.4×	15 1.0×	25	178
Geneviève Le Templier Canada	4	50 0.7×	15 0.3×	6 0.2×	4 0.1×	4 0.3×	6	137
Matteo Augello Italy	9	102 1.3×	11 0.2×	2 0.1×	25 0.9×	11 0.7×	24	164
Lisa Staadegaard Netherlands	7	29 0.4×	26 0.5×	2 0.1×	2 0.1×	17 1.1×	10	136
K Fleischer Germany	8	35 0.5×	54 1.0×	2 0.1×	6 0.2×	16 1.1×	31	177
Laura Ziegler Germany	4	250 3.3×	33 0.6×		4 0.1×	12 0.8×	4	280
Rita A. Reik United States	7	62 0.8×	9 0.2×		5 0.2×	7 0.5×	16	168

Countries citing papers authored by M. Caporale

Since Specialization

Citations

This map shows the geographic impact of M. Caporale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Caporale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Caporale more than expected).

Fields of papers citing papers by M. Caporale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Caporale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Caporale. The network helps show where M. Caporale may publish in the future.

Co-authorship network of co-authors of M. Caporale

This figure shows the co-authorship network connecting the top 25 collaborators of M. Caporale. A scholar is included among the top collaborators of M. Caporale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Caporale. M. Caporale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Puglia, Ilaria, et al.. (2024). Validation of a focus reduction neutralization test (FRNT) to rapidly titrate human SARS-CoV-2 neutralizing antibodies by using the CTL Immunospot S6 universal analyzer. Heliyon. 10(15). e34925–e34925.

Puglia, Ilaria, et al.. (2024). Low pathogenic human coronaviruses during the first waves of COVID-19 in Italy.. PubMed. 60(2).

Spedicato, Massimo, Daniela Malatesta, Maria Loredana Colaianni, et al.. (2024). A cell-adapted SARS-CoV-2 mutant, showing a deletion in the spike protein spanning the furin cleavage site, has reduced virulence at the lung level in K18-hACE2 mice.. Virology. 592. 109997–109997. 1 indexed citations

Curini, Valentina, Massimo Ancora, M. Caporale, et al.. (2023). Evaluation of next generation sequencing approaches for SARS-CoV-2. Heliyon. 9(11). e21101–e21101. 5 indexed citations

Amato, Laura, Luca Candeloro, Arturo Di Girolamo, et al.. (2022). Epidemiological and genomic findings of the first documented Italian outbreak of SARS-CoV-2 Alpha variant of concern. Epidemics. 39. 100578–100578. 5 indexed citations

Spedicato, Massimo, M. Caporale, Liana Teodori, et al.. (2022). Reemergence of an atypical bluetongue virus strain in goats, Sardinia, Italy. Research in Veterinary Science. 151. 36–41. 8 indexed citations

Calistri, Paolo, Laura Amato, Ilaria Puglia, et al.. (2021). Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads in nasopharyngeal swabs. International Journal of Infectious Diseases. 105. 753–755. 54 indexed citations

Calistri, Paolo, Maria Luisa Danzetta, Laura Amato, et al.. (2021). Epidemiological Significance of SARS-CoV-2 RNA Dynamic in Naso-Pharyngeal Swabs. Microorganisms. 9(6). 1264–1264. 9 indexed citations

Bartolomeo, Maria Di, Monica Niger, Maria Maddalena Laterza, et al.. (2016). Safety and efficacy profile of ramucirumab alone or combined with paclitaxel in metastatic gastric cancer (MGC): A real-life overview of compassionate-use named patients (pts) (RAMoss study). Annals of Oncology. 27. vi216–vi216.

10.

Mennitto, Alessia, Christian Cotsoglou, M. Caporale, et al.. (2016). Perioperative triplet chemotherapy plus bevacizumab (bev) in patients with borderline resectable colorectal cancer liver metastases (CLM): Preliminary safety and activity. Annals of Oncology. 27. vi161–vi161.

11.

Falvella, Felicia Stefania, Chiara Cremolini, Rosalba Miceli, et al.. (2016). Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab. The Pharmacogenomics Journal. 17(4). 331–336. 10 indexed citations

12.

Pietrantonio, Filippo, Chiara Cremolini, Lorenza Rimassa, et al.. (2016). O-013 A new nomogram for estimating 12-weeks survival in patients (pts) with chemorefractory metastatic colorectal cancer (mCRC). Annals of Oncology. 27. ii122–ii122.

13.

Pietrantonio, Filippo, Federica Perrone, Alessia Mennitto, et al.. (2016). Toward the molecular dissection of peritoneal pseudomyxoma. Annals of Oncology. 27(11). 2097–2103. 53 indexed citations

14.

Bartolomeo, Maria Di, Alessandro Pellegrinelli, Roberto Iacovelli, et al.. (2015). Association with programmed death ligand-1 (PDL-1) expression and Helicobacter Pylori infection in patients with non-diffuse type gastric carcinoma. Annals of Oncology. 26. vi93–vi93. 2 indexed citations

15.

Baratti, Dario, Shigeki Kusamura, Filippo Pietrantonio, et al.. (2015). Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colorectal cancer at high risk for the development of peritoneal metastases. A matched case-control study. Annals of Oncology. 26. vi42–vi42. 1 indexed citations

16.

Cremolini, Chiara, Rosalba Miceli, Monica Niger, et al.. (2015). Risk of thromboembolic events (TEE) in metastatic colorectal cancer (mCRC) patients with single nucleotide polymorphisms (SNPs) in Factor V Leiden (FVL), Prothrombin, Plasminogen Activator Inhibitor-1 (PAI-1) and Methylenetetrahydrofolate Reductase (MTHFR). Annals of Oncology. 26. vi41–vi41. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact